Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
IFA says it is ‘reasonable to expect’ more cases of bluetongue disease to be identified in coming weeks

IFA says it is ‘reasonable to expect’ more cases of bluetongue disease to be identified in coming weeks

Center-right Irish Independent
Owner: Van Puijenbroek & Baert Families, Thomas Leysen
Hospital officials: Lehigh Valley Hospital—Dickson City structurally sound

Hospital officials: Lehigh Valley Hospital—Dickson City structurally sound

Healthcare Triangle announces 1-for-60 reverse stock split

Healthcare Triangle announces 1-for-60 reverse stock split

Bowel cancer is surging in young people in Britain - but not in other parts of Europe. Now doctors think they know why...

Bowel cancer is surging in young people in Britain - but not in other parts of Europe. Now doctors think they know why...

USFDA Grants Orphan Drug Status to Zydus' Desidustat for Sickle Cell Disease

USFDA Grants Orphan Drug Status to Zydus' Desidustat for Sickle Cell Disease

Indeterminate Medical Dialogues
Owner: Meghna A. Singhania & Prem Aggarwal
Hospital officials: Lehigh Valley Hospital—Dickson City structurally sound

Hospital officials: Lehigh Valley Hospital—Dickson City structurally sound

Healthcare Triangle announces 1-for-60 reverse stock split

Healthcare Triangle announces 1-for-60 reverse stock split

Bowel cancer is surging in young people in Britain - but not in other parts of Europe. Now doctors think they know why...

Bowel cancer is surging in young people in Britain - but not in other parts of Europe. Now doctors think they know why...

USFDA Grants Orphan Drug Status to Zydus' Desidustat for Sickle Cell Disease

USFDA Grants Orphan Drug Status to Zydus' Desidustat for Sickle Cell Disease

IFA says it is ‘reasonable to expect’ more cases of bluetongue disease to be identified in coming weeks

IFA says it is ‘reasonable to expect’ more cases of bluetongue disease to be identified in coming weeks

Show More

Video Stories

YouTube video thumbnail: Hims & Hers Offers Cheaper Weight-Loss Pill in a Shock to Novo
Play
Hims & Hers Offers Cheaper Weight-Loss Pill in a Shock to Novo
YouTube video thumbnail: What to Know About South Carolina’s Big Measles Outbreak and Who Is Most at Risk
Play
What to Know About South Carolina’s Big Measles Outbreak and Who Is Most at Risk
YouTube video thumbnail: Trump Announces Prescription Drug Website TrumpRx
Play
Trump Announces Prescription Drug Website TrumpRx
YouTube video thumbnail: What Is Biocomputing?
Play
What Is Biocomputing?

Video Title

Press Releases

Premier Alan Winde and MEC Ivan Meyer brief media on coordinated response to Foot-and-Mouth disease in Western Cape, 8 Feb

Premier Alan Winde and MEC Ivan Meyer brief media on coordinated response to Foot-and-Mouth disease in Western Cape, 8 Feb

Premier Alan Winde and MEC Ivan Meyer brief media on coordinated response to Foot-and-Mouth disease in Western Cape, 8 Feb

Premier Alan Winde and MEC Ivan Meyer brief media on coordinated response to Foot-and-Mouth disease in Western Cape, 8 Feb

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions